Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

IrelandBack to Ireland

Clinical trials in Galway – page 3

104 clinical trials in Galway, Ireland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Galway at a glance
104
clinical trials
  • Paediatric trials0
  • Research sites2
Type of trial
Recruitment status
Quick filters

104 trials in Galway

Open in trial search

Acute myeloid leukaemia

Recruiting

Study on Revumenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Crohn's disease

Recruiting

Study on the Effectiveness and Safety of Vedolizumab and Upadacitinib in Adults with Moderate to Severe Crohn's Disease

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Upadacitinib
  • Sponsor:Takeda Development Center Americas Inc.

Endometrial cancer+13

Recruiting

Study on Ifinatamab Deruxtecan for Patients with Recurrent or Metastatic Solid Tumors

InvestigationalNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Ifinatamab Deruxtecan
  • Sponsor:Daiichi Sankyo Inc.

Non-small cell lung cancer stage III+3

Recruiting

Study of Volrustomig and Drug Combination for Patients with Early-stage Resectable Non-small Cell Lung Cancer

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB

Non-small cell lung cancer

Recruiting

Study of Adagrasib Alone and with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Mirati Therapeutics Inc.

Decreased appetite

Recruiting

Study of ART27.13 for Patients with Cancer-Related Anorexia and Weight Loss

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Artelo Biosciences Limited

Critical illness

Recruiting

Study on Preventing Cardiovascular Collapse in Critically Ill Adults Using Noradrenaline Tartrate During Tracheal Intubation

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Noradrenaline Tartrate
  • Sponsor:Universita' Degli Studi Di Torino

Study on the Effects of Baricitinib and Drug Combination for Adults with Severe Community-Acquired Pneumonia, Severe Influenza, or Severe and Moderate COVID-19

Recruiting
Registered drugNo placebo
Countries:IrelandIreland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Amoxicillin Sodium
  • Sponsor:Universitair Medisch Centrum Utrecht

HIV infection+1

Recruiting

Study on Semaglutide for Weight Loss in Patients with HIV and Obesity

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:University College Dublin

Triple negative breast cancer

Recruiting

Study of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Triple-Negative Breast Cancer Post-Surgery

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Merck Sharp & Dohme LLC

Plasma cell myeloma refractory

Recruiting

Study Comparing Mezigdomide, Bortezomib, and Dexamethasone with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Celgene Corp.

Plasma cell myeloma

Recruiting

Study of Teclistamab and Lenalidomide as Maintenance Treatment for Newly Diagnosed Multiple Myeloma Patients After Stem Cell Transplantation

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Lenalidomide
  • Sponsor:Emn Trial Office S.r.l. Impresa Sociale

Other cities in Ireland

The busiest research cities in the country

All 16 cities in Ireland

Clinical research in Galway

What the registry says about research in the country

01 Oncology Research

Groundbreaking studies focusing on multiple myeloma, lung cancer, and various forms of breast cancer. Research includes novel therapeutic combinations and targeted treatments for both early-stage and metastatic conditions.

  • Lung Cancer Therapeutics
  • Multiple Myeloma Treatments
  • Breast Cancer Innovations

Investigating new treatment approaches using advanced targeted therapies and immunotherapy combinations.

02 Hematological Studies

Advanced research into blood-related cancers, particularly chronic lymphocytic leukemia and lymphoma. Studies evaluate novel drug combinations and treatment duration optimization.

  • CLL Treatment Protocols
  • B-Cell Lymphoma Therapies
  • Treatment Duration Studies

Focusing on personalized treatment approaches based on measurable residual disease monitoring.

03 Cardiovascular Research

Innovative studies addressing hypertension and cardiovascular health, including research on obesity-related cardiovascular conditions and new therapeutic approaches.

  • Resistant Hypertension
  • Coronary Artery Disease
  • Cardiovascular Risk Management

Exploring novel interventions for blood pressure control and atherosclerosis prevention.

04 Dermatology Studies

Clinical investigations focusing on chronic skin conditions, particularly atopic dermatitis and hidradenitis suppurativa, testing new therapeutic options.

  • Moderate to Severe Eczema
  • Inflammatory Skin Conditions
  • Combined Therapy Approaches

Evaluating advanced treatments for patients requiring systemic therapy.

Back to IrelandAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.